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Transgenic Xenopus laevis tadpoles that express a dominant negative form of the thyroid hormone receptor (TRDN) controlled by the cardiac
actin muscle promoter (pCar) develop with very little limb muscle. Under the control of the tetracycline system the transgene can be induced at
will by adding doxycycline to the rearing water. Pre-existing limb muscle fibers begins to disintegrate within 2 days after up-regulation of the
TRDN transgene. The muscle cells do not die even after weeks of transgene exposure when the myofibrils have degenerated completely and the
tadpole is nearing death. A microarray analysis after 2 weeks of exposure to the transgene identified 24 muscle genes whose expression was
altered in such a way that they might cause the muscle phenotype. These candidate genes are normally activated in growing limb muscle but they
are repressed by the TRDN transgene. Several of these genes have been implicated in mammalian myopathies. However, the expression of only
one of these genes, calsequestrin, is down-regulated in 1 day and therefore might initiate the degeneration. Calsequestrin is one of several affected
genes that encode proteins involved in calcium sequestration, transport and utilization in muscle suggesting that uncontrolled calcium influx into
the growing limb muscle fibers causes rhabdomyolysis. Many of the same genes that are down-regulated in the tail at the peak of metamorphic
climax just before it is resorbed are suppressed in the transgenic limb muscle in effect turning the limb growth program into a tail resorption
program.
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The multiple axes of a Xenopus laevis tadpole limb bud are
established by Nieuwkoop–Faber (NF) stage 52 (Nieuwkoop
and Faber, 1956) when the limb is an oblong structure with
undifferentiated cells (Cameron and Fallon, 1977). The
subsequent growth and differentiation of the various limb cell
types is controlled by thyroid hormone (TH). The earliest effect
of TH on limb development is stimulation of DNA replication
in all cell types (Brown et al., 2005; Schreiber et al., 2001).
Limb growth is followed by the formation of the characteristic
cell types and their terminally differentiated proteins. Nerves
grow into the limb as it elongates even before the appearance of
muscle fibers. The limb is fully formed before it is functionally
innervated. Tadpoles convert from tail to leg swimming at the
climax of metamorphosis (NF60) before the tail is resorbed
(Marsh-Armstrong et al., 2004).⁎ Corresponding author.
E-mail address: brown@ciwemb.edu (D.D. Brown).
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doi:10.1016/j.ydbio.2006.12.031A series of transgenic experiments, in which different cell
type specific promoters control the expression of a dominant
negative thyroid hormone receptor alpha (TRDN) revealed that
the multiple programs of limb development are controlled
independently by TH (Brown et al., 2005). A ubiquitously
expressed promoter driving the TRDN reporter represses TH-
induced DNA synthesis in the early limb bud (Schreiber et al.,
2001) while cell-type specific promoters inhibit cell autono-
mously the differentiation of muscle, innervation of the limb
muscle, and the growth of the limb skeleton (Brown et al.,
2005). The death of muscle in the tail at metamorphic climax is
also a cell autonomous TH-induced program (Das et al., 2002;
Nakajima and Yaoita, 2003; Yaoita and Nakajima, 1997).
Overexpression of the same TRDN transgene that causes
muscle degeneration in limbs protects tail muscle from TH-
induced resorption (Das et al., 2002). A transgenic tadpole with
the X. laevis cardiac actin promoter (pCar) driving the TRDN
transgene dies at the climax of metamorphosis. The animal's
limbs never function because they have almost no muscle (Das
et al., 2002).
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compare the TH-induced gene expression profiles in the
growing limb and brain with the tail (Das et al., 2006). Not
only do the growth and resorption programs differ greatly but
also in some cases the same genes had opposite responses to the
hormone in tail compared to limb. In this paper we have
investigated the limb muscle wasting induced by the TRDN
transgene. We prepared transgenic animals in which the pCar
promoter drives the expression of the TRDN reporter under the
control of the tetracycline inducible system. Induction of the
transgene causes the degeneration of limb muscle specifically
without affecting the other cell types that differentiate in the
limb (Brown et al., 2005). A microarray analysis of the gene
expression profile reveals a small set of muscle genes whose
expression pattern is inhibited from the up-regulation that
occurs normally at metamorphosis in the muscle growth
program. These same genes are down-regulated in the muscle
death program that occurs normally during tail resorption.
Several of these candidate genes have been implicated in human
myopathies.Materials and methods
The plasmids used for transgenesis
Control of the expression of a transgene by the tetracycline system (Urlinger
et al., 2000) has been applied to X. laevis development (Das and Brown, 2004).
One plasmid called pCS2+(tetO)TRDN/GFP has the tet operator adjacent to a
dominant negative form of X. laevis thyroid receptor alpha. This mutant receptor
lacks 12 amino acids from its C-terminus, and it is fused to GFP at its carboxy
terminus by a small flexible linker. The TRDN part of the resulting protein has a
nuclear localization signal so that the fluorescent protein can be visualized in the
nucleus. The second plasmid has the X. laevis cardiac actin promoter (pCar)
driving a modified tetracycline repressor (pCar/rTA2S-M2). This system is
under positive control so that addition of the tetracycline derivative, doxycycline
(Dox), induces expression of the TRDN/GFP transgene. The transgenesis
procedure (Kroll and Amaya, 1996) used a mixture of the 2 plasmids (Das and
Brown, 2004). A doubly transformed male parent was raised to sexual maturity
and bred with a wild type female. The transgene can be induced in half of the
progeny. Mixtures of DNAs are often integrated together presumably in tandem
arrays (Marsh-Armstrong et al., 2004).
Raising tadpoles for microarray limb samples
The F1 progeny were raised to NF 55 without the inducer. Batches of 20
tadpoles were grown in 4 l of 0.1 MMR containing 50 μg/ml doxycycline
hyclate (Dox; Sigma) (Das and Brown, 2004). The tadpoles were fed daily and
the rearing water was changed twice each week. After 2 weeks and 6 weeks of
Dox treatment the tadpoles had advanced to NF 56 and 61, respectively. The
latter developmental stage (NF61) is metamorphic climax when the endogenous
TH is highest. By NF62 the control tadpoles are swimming with their legs, and
all of the transgenic animals at the same stage have the characteristic paralyzed
phenotype. Control and transgenic tadpoles were sorted by their GFP
fluorescence and their hind limbs were removed for RNA extraction. If allowed
to continue development all of the paralyzed transgenic tadpoles will soon die.
The fourth RNA sample was isolated from the hind limbs of control frogs (NF
66) that were raised in 50 μg/ml of Dox for 2 weeks after completing
metamorphosis. This concentration of the inducer has no effect on the
development or growth of normal tadpoles or frogs. The tadpoles and frogs
were fed throughout the experiment.
Three separate samples of hind limbs were collected from each of the 4
groups of animals. For the control and transgenic 2-week tadpoles, each sample
consisted of hind limbs from 12 tadpoles. We used limbs from 6 tadpoles perreplicate for the 6-week Dox treated climax transgenic tadpoles and limbs from 4
control frogs for each sample.
RNA purification, probe synthesis, and microarray hybridization
After amputation the limbs were homogenized immediately in Trizol
(Invitrogen) to purify total RNA according to the manufacturer's protocol.
Probes for the microarray were synthesized with the Agilent Low RNA Input
Fluorescent Linear Amplification Kit (Agilent Kit #5184-3523) that incorpo-
rates the fluorescent nucleotide Cy3 CTP (Perkin Elmer). The universal standard
labeled with Cy5 CTP was derived from all stages of whole tadpoles and has
been described (Das et al., 2006). These cRNA probes were hybridized with a
second version of Agilent X. laevis microarray slides (AMADID #013214).
Each slide contains 21,654 sense oriented 60-mer oligonucleotides from the
complete X. laevis Unigene list that was issued in February 2004 (Build 48).
Duplicate entries and other details of these arrays have been described (Das et
al., 2006). Since each of the four experimental points were performed in
triplicate the statistical significance of expression values could be evaluated by
the False Discovery Rate (FDR) method (Benjamini and Hochberg, 1995;
Sharov et al., 2005). We only scored gene expression changes that differed from
the control with an FDR value of less than 0.05. The microarray data are
presented as the ratio of the log intensity of triplicate hybridization values
(2-week and 6-week transgenic limbs and control frog limbs) relative to the
control tadpole limb. The tail expression data is derived from our previous array
analysis (Das et al., 2006). The NF62 climax tail values are compared to control
tail at NF54. The data discussed in this publication have been deposited in
NCBI's Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/)
and are accessible through GEO Series accession number GSE5249. It can also
be accessed at our web site (http://www.ciwemb.edu/brownlab/index.html).
Histology, immunostaining and in situ hybridization
The methods for hematoxylin and eosin staining, immunocytology and in
situ hybridization have been described (Cai and Brown, 2004). The antibodies
used in this study were directed against skeletal muscle myosin (fast) clone
My32 (Sigma, product No. M4276), Alexa-568/488 secondary antibody from
Molecular Probes and anti-GFP polyclonal antibody (Torrey Pines Biolab).
Probes for in situ hybridization were digoxygenin-labeled antisense RNA. We
purchased cDNAs from ATCC to make the probes for the in situ hybridizations.
For electron microscopy frontal and cross sections of limbs were fixed with
glutaraldehyde and paraformaldehyde followed by osmium tetroxide and uranyl
acetate, dehydrated in ethanol and embedded in epoxy. Sections were cut at
about 90 nm thickness, stained with lead citrate and imaged on an FEI Techai 12
using a Gatan camera and software.Results
Induction of the pCar/TRDN phenotype
The pCar/TRDN transgenic tadpoles form limbs that have
almost no muscle (Das et al., 2002). In order to study this
phenotype in greater detail we prepared transgenic X laevis with
the pCar/TRDN–GFP transgene controlled by the positive
tetracycline inducible system (Urlinger et al., 2000). In the
presence of the inducer, doxycycline (Dox), the fused transgenic
protein (TRDN–GFP) can be detected in limb muscle nuclei
when specialized muscle proteins are first synthesized (NF54)
(Fig. 1). The co-localization of GFP and myosin confirm that the
pCar promoter drives expression specifically in differentiated
muscle fibers. When the inducer was added at NF54 the muscle
phenotype developed as the tadpoles advance to the climax of
metamorphosis. The tadpoles die at NF62 after gill resorption but
before tail resorption (Brown et al., 2005). When the TRDN
Fig. 1. The transgene is expressed exclusively in muscle. A transgenic limb
(NF55) frontal section simultaneously reacted with (A) an antibody to GFP (red)
and DAPI (blue); (B) an antibody to myosin (My32, green) and DAPI (blue); (C)
merge of panels A and B without the DAPI. The scale bar=200 μm.
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differentiated limb muscle fibers degenerate.
The pCar/TRDN-paralyzed limb muscle was analyzed by
light and electron microscopy. Muscle fibers have disintegrated,
and the muscle nuclei clump together within the bundles that
previously contained the myofibrils (Fig. 2). These nuclei are
convoluted with prominent nucleoli. Residual patches of
parallel filaments (Fig. 2B) are often visible. Mitochondria are
clumped as are the sarcoplasmic reticulum. In contrast to tail
muscle cells (Das et al., 2002) that are induced by TH to resorb
these degraded limb muscle cells were negative for both active
caspase-3 and the TUNEL reaction for apoptosis. Even at thelatest stages of the phenotype the limb muscle cells are not dead.
Satellite muscle cells can be identified with an antibody to Pax
7. These cells continue to incorporate Brdu (Fig. S1). As will be
shown many muscle genes including the muscle cell specific
transcription factors are expressed even at the late stages of the
phenotype. In support of the idea that the muscle nuclei do not
die we removed the inducer Dox and reversed the phenotype of
one transgenic NF58 tadpole that had developed a visible limb
phenotype. The animal recovered and switched to leg swim-
ming at metamorphic climax (data not shown). Since develop-
ment of these transgenic tadpoles continues inexorably to
climax the time for recovery at NF58 is too narrow for efficient
recovery of most tadpoles with the limb phenotype.
We have induced metamorphosed transgenic small frogs
with Dox for as long as 4 months. These animals grow more
slowly than controls and develop abnormal but functional
limbs. They never become paralyzed but left in the inducer the
frogs stop eating and die. Histology of their limbs revealed
normal but smaller muscle bundles than control frogs (data not
shown). The inducer was removed from the rearing water of two
of these frogs, and they were raised to sexual maturity. They
retained a deformed leg structure but otherwise recovered.
Therefore the up-regulation of the transgene after metamor-
phosis has a demonstrable but much less drastic affect on the
frog limb muscle than it does on tadpoles.
Gene expression profile of the developing transgenic limb
In order to probe the molecular basis of this wasting
phenotype, we carried out a microarray analysis on the hind
limbs of normal and Dox induced transgenic tadpoles and
control frogs (Fig. 3). The gene expression profiles of the
control and 2-week samples from sibling tadpoles that had been
raised in the same container with Dox are remarkably similar.
Out of the 21,654 entries on the microarray only 42 and 67
genes are significantly up- and down-regulated, respectively, in
the transgenic 2-week limb compared to the control limbs
(Table 1). Many more genes are differentially expressed
4 weeks later (6-week time point), when the transgenic tadpoles
had progressed to the climax of metamorphosis, and in the
control frog limb. The final column of Table 1 includes the
number of genes that are up- or down-regulated in the tail at
climax (NF62) compared to a growing tail (NF54). These data
were obtained in our previous microarray study (Das et al.,
2006). Note that there are more than twice as many up-regulated
genes as down-regulated genes in the tail at climax (NF62) even
though the tail has been activated to die and resorb. Most of the
up-regulated genes in the tail are expressed in fibroblasts while
the majority of down- regulated genes are expressed in muscle.
The developmental changes in gene expression fall into
classes (Fig. 4) that reflect the differentiation of the several cell
types in the limb, the influence of TH, and the effect of the
transgene. Gene expression values of transgenic limbs at the 2-
week and 6-week time points as well as the control frog limbs
are always compared with those of the GFP negative control
tadpole limbs at NF56 (Fig. 3). Although we will concentrate on
muscle-specific genes, the array experiments document the
Fig. 3. Design of the limb microarray experiment. Hind limbs were removed from the circled stages for RNA extraction. In the text the expression results always
compare the transgenic limbs and the frog limbs with the GFP negative NF56 controls.
Fig. 2. Electron micrographs of the limb muscle phenotype at NF61. (A, C) control, and (B, D) pCar/TRDN limb. Panels A and B are longitudinal sections and panels
C and D are cross sections. The sibling control and pCar/TRDN tadpoles were raised for 6 weeks in Dox. The scale bar=5 μm.
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Table 2
Primary candidate genes
Accession
number
Gene name 2
weeks
6
weeks
Frog Tail
NF62
In
situ
BC043842 Phosphoglycerate
mutase 2
0.13 0.28 56.91 0.03 M+
BC045082 Enolase 3 0.27 0.31 125.57 0.07 M+
BC043830 Phosphorylase kinase 0.35 0.4 16.45 0.63 M+
AB003080 Troponin C, slow 0.17 0.09 3.28 NS M+
BX850052 Fast troponin I 0.35 NS 8.48 NS M+
M87307 Tropomyosin 0.43 NS 14.20 0.36 M+
CD255184 Myosin heavy chain, E3 0.17 0.64 5.11 0.38 M+
BC046739 Actin, alpha 1 0.25 0.24 22.44 0.11 M+
BC042340 LIM domain binding 3 0.48 NS 12.48 0.33 M
BC041221 LIM domain protein 0.59 NS 14.71 0.10 M+
BC054224 Myozenin 1 0.34 NS 74.83 0.23 M+
BC046947 Calsequestrin 1 0.17 0.39 69.63 0.27 M+
BC044063 ATPase, Ca++ 0.29 0.57 7.07 NS M+
BC042249 Creatine kinase M 0.29 NS 8.61 NS M+
CB945142 Creatine kinase B 0.52 NS 24.70 0.33 M
CF547537 Choline dehydrogenase 0.35 0.35 9.18 NS
BX847508 Cyt. c oxidase assembly 0.39 NS 10.53 0.23 M
BX851926 Ryanodine receptor 3 0.43 NS 4.85 0.37 M
BC045081 AchR alpha 0.52 0.68 1.54 0.48 M
U19612 AchR epsilon 0.53 NS 4.63 0.31 M
BC043628 AchR delta 0.58 NS 2.36 0.21 M
BJ029671 Sirtuin 1 0.57 0.62 25.62 0.23 M
BC048222 Thrombospondin 3 0.57 NS 1.58 0.52
AY043260 Protein phosphatase 2a 0.6 NS 1.62 0.26 M
BC046852 Bridging integrator 1 0.49 NS 1.91 0.44 M
BX851794 Mg(2+) transporter 0.51 NS 1.94 0.63
CB984281 Mitoch. ADP/ATP
translocase
0.68 NS 5.90 0.24 M
CD099943 Unknown 0.68 0.69 8.00 NS
Table 1
Summary of differentially expressed genes in the limb and tail
2 weeks 6 weeks Frog Tail NF62 a
Up total no. 42 1401 4242 1716
Down total no. 67 1915 3054 742
a Tail data compares expression at climax (NF62) with tail at NF54 from Das
et al., 2006. There are 21,654 oligonucleotides on the array.
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formation of cartilage, bone, and bone marrow that are not
affected by expression of the transgene in muscle. At the 6-
week time point, which is the climax of metamorphosis (NF61),
these non-muscle cell type specific genes invariably change
their expression in the same direction as they do in the frog
limb. We call this pattern of expression for TH-controlled genes
that are unaffected by the transgene ns-up-up (Fig. 4G) or ns-
down-down (Fig. 4I) referring to the three successive develop-
mental stages compared to the control tadpole i.e. unchanged
(ns) in the 2-week transgenic, elevated (up) in both the 6-week
transgenic and the frog limb. This class of genes (ns-up-up)
includes the muscle specific transcription factors that are
expressed in myoblasts before the pCar promoter is activated
(Table S1). There are 8 tadpole-specific muscle genes that are
down-regulated at metamorphosis and follow the kinetics of
“ns-down-down” (Fig. 4I, Table S1). Tadpole-specific skin
genes also exhibit this pattern (for example, gene 19 (U41861)
(Furlow et al., 1997). The majority of genes (13,329) on the
array do not change their expression during limb development
at these three time points (ns-ns-ns) (Fig. 4F). There are 49Fig. 4. Gene expression profiles and the number of genes on the array for each
profile in parenthesis. (A) Down-down-up (14); (B) down-ns-up (18); (C) ns-ns-up
(3284); (D) ns-down-up (28); (E) up-up-down (3); (F) ns-ns-ns (13329); (G) ns-up-
up (876); (H) ns-up-ns. (448); (I) ns-down-down (1450). The horizontal linemarks
the gene expression value of the control tadpole limb that the three other limb
hybridization values are compared with. Each profile has the 2-week, 6-week and
frog values from left to right. Panels A, B, and E are primary candidate genes.
Panels C and D are secondary candidate genes; panel F is unchanged during
development; panelsG and I change during development but are not affected by the
transgene; panel H follows the endogenous TH concentration. An FDR value of
<0.05 was used to score a gene as up- or down-regulated.
BJ041930 Unknown 0.51 NS 1.85 0.41
BX854361 ADP-ribosyltransferase 1 0.58 NS 11.60 0.51
AW764727 FGF receptor substrate 3 0.47 0.63 9.97 0.23
BE026509 Unknown 0.38 0.31 2.48 NS
Selected secondary candidate genes
BC046673 Aldolase A,
fructose-bisphosphate
NS NS 16.21 0.19 M
BC045015 Lactate dehydrogenase A NS NS 10.66 0.20 M
U39669 Pyruvate dehydrogenase NS NS 5.35 0.38 M
BC045100 Phosphofructokinase,
muscle
NS 0.61 23.60 0.16 M
BC043781 Phosphoglycerate kinase
1
NS NS 9.21 0.11 M
BC046864 Triosephosphate
isomerase 1
NS NS 2.42 0.38 M
BC054279 EF1 alpha 2 NS NS 338.77 4.95 M
M, known muscle expression; +, in situ confirmation of down-regulation at the
6-week time compared to a control at the same stage.
NS, not significant compared to 2-week control.muscle genes on the array with an unchanged expression profile
(Table S1). The in situ results of two of these genes, titin and
desmin, are shown in Fig. S2.
Candidate genes
Several considerations narrow the search for candidate genes
that might be involved in the muscle phenotype. Gene(s)
responsible for the phenotype should differ in their expression
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2 weeks of Dox induction, because the limb muscle phenotype
is detectable by that time. We have established a more precise
time for the onset of the muscle destruction phenotype (see
below). A candidate muscle gene that normally is down-
regulated at metamorphosis should be up-regulated in the
transgenic limb. We refer to this pattern as an “up-up-down”
profile (Fig. 4E). Only 3 of the 42 genes that are up-regulated in
the transgenic limbs after 2 weeks of Dox induction have the
profile of continued up-regulation at 6 weeks and finally down-
regulation in the frog limb. Their expression changes are less
than two-fold. These genes (uroplakin 1A, transportin 1, and an
unidentified EST) are not known to be involved in muscle
development or maintenance.
Genes having the opposite expression profile (down-down-
up and down-ns-up) (Figs. 4A and B) could initiate the
phenotype. These genes are down-regulated in the transgenic
limb after 2 weeks of Dox, and either down-regulated or
unchanged in the 6-week transgenic but always up-regulated in
the control frog limb. Only 67 of the 21,654 entries on the
microarray are reduced in expression after 2 weeks of Dox
treatment compared to the sibling control values. 32 of these 67
genes have the relevant gene expression profile (Table 2). The
majority (24) of these genes are known to be expressed in
muscle. The muscle localization and the change in expression
caused by the transgene of two candidate genes (LIM and actin)
is shown in Fig. 5. These two genes and most of the other
candidate genes are up-regulated in the control limb by thyroidFig. 5. In situ hybridizationwith panels A–F, alpha actin (BC046739) and panels A′–F
and B′, cross sections of NF 62 tail; panels C and C′, are frontal sections of control NF5
10 nM T3; panels E, E′, frontal section of control NF61 limb; panels F, F′, pCar tranhormone and down-regulated in the control tail at the climax of
metamorphosis. Candidate genes whose expression profiles
have been confirmed by in situ hybridization are noted in Table
2. The remainder of the genes in Table 2 has not been studied
further so they too might be expressed in muscle. 25 of these 32
genes are down regulated in the tadpole tail at climax (Table 2).
The other 7 are unchanged. Many muscle genes continue being
expressed in the limb even at the latest stage just before death of
the transgenic tadpoles (Table S1; Fig. S2).
The kinetics of muscle degradation and muscle gene
down-regulation
The candidate genes that are down-regulated in the
microarray after 2 weeks exposure to the inducer could include
genes that respond directly or indirectly to the TRDN transgene.
We analyzed the kinetics of muscle fiber degradation at varying
times after induction of the transgene by whole mount
immunocytology with an antibody to myosin (Fig. 6).
Remarkably, patches of muscle fiber disruption were seen as
early as 2 days after addition of the inducer Dox. The
destruction increased at 4 days and was extensive after 1
week of exposure to the transgene (Fig. 6). We screened 7 of the
most dramatically regulated candidate genes by in situ
hybridization for the earliest time that down-regulation could
be detected presuming that down-regulation of the gene(s)
causing the phenotype must precede visible degradation of
muscle fibers (Table 3). Only calsequestrin was down-regulated′, LIM (BC041221). Panels A andA′, cross sections of control NF55 tail; panels B
6 limb. Panels D and D′, are frontal sections of NF56 limb treated for 3 days with
sgenic limb that was induced for 6 weeks. with Dox. Scale bars=200 μm.
Fig. 6. Kinetics of limb muscle fiber degradation after inducing the transgene by the addition of the inducer, Dox. Whole mount My32 (myosin) immunostain.
Transgenic tadpoles at NF 55 were induced with Dox for 2 days, 4 days, and 1 week. Scale bar=200 μm.
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expression at day 1 but down-regulated partly or extensively by
4 days (Table 3; Fig. S3). The slightly later down-regulation of
most of these candidate genes compared to calsequestrin does
not rule out their role in the degradation phenotype since the
destruction begins in small patches (Fig. 6) and does not involve
all of the muscle until 1 week of Dox treatment. In addition
there are another 17 muscle genes that have not been tested at
these early time points.
Muscle, glycolysis and mitochondrial energy related genes are
influenced by the transgene
We have organized the genes on the array that are directly or
indirectly influenced by the transgene and listed them inTable 3
Expression kinetics of candidate genes
Gene name 1d a 2d 4d 1w
Calsequestrin 1 D D D D
Actin, alpha 1 NS NS D D
Phosphoglycerate mutase 2 NS NS D D
Enolase 3 NS NS pD D
Phosphorylase kinase NS NS pD D
ATPase, Ca++ NS NS NS D
D, down-regulated; pD, partially down-regulated; NS, not changed.
a Time after addition of Dox. Gene expression was assessed by in situ
hybridization and in each case compared to a control limb.supplementary Tables 1–4. The kinetic patterns of ns-down-up
(18 genes), and ns-ns-up (2184 genes) are interpreted as indirect
response genes (Table S1). 536 genes with the profile ns-ns-up
are expressed at least twice the level in the frog as in the control
tadpole limb. This list includes genes encoding muscle genes
(Table S1), glycolytic enzymes (Table S3), and many of the
same genes involved in the generation of energy in muscle
mitochondria (Table S4) that are down-regulated in the tail at
metamorphic climax and induced by TH in growing tadpole
limbs (Das et al., 2006).
Many of the candidate muscle genes have been implicated in
human myopathies or shown to cause muscle degeneration in
mouse knock outs. These will be discussed later. Along with the
earliest responding gene, calsequestrin, a significant number of
the primary candidate genes are involved in calcium delivery to
or utilization by muscle.
In a previous paper (Das et al., 2006) we studied the gene
expression changes in tadpole tail, limb and brain induced with
TH. The sampling of X. laevis genes is large enough on these
arrays to identify functional categories in which a large non-
random number of genes are altered in expression by the
hormone. Two such functional categories are the glycolysis
pathway and the complexes that transfer electrons and
synthesize ATP in mitochondria. These metabolic pathways
are especially important for muscle function, and the expression
of the genes encoding these functions is activated in growing
tail muscle and up-regulated by TH in growing limb muscle
Fig. 7. Early disappearance of calsequestrin mRNA in hind limb muscle after the up-regulation of the TRDN transgene with Dox. Panels A, B, E–H are in situ
hybridization; panels C and D are the same sections as panels A and B immunostained with My32 (green). Panels A, C, E, and G are uninduced NF 55 transgenic
tadpole limb sections; panels B, D, F, and H are limb sections of NF 55 transgenic tadpoles induced for 1 day with Dox. (A, B) calsequestrin; (E, F) actin; (G, H)
SERCA Ca(2+)-ATPase. Scale bar=200 μm.
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glycolytic enzymes (Suppl. Table 3). Fourteen of these genes
are up-regulated in the control frog limb, and either down-
regulated or unchanged in the transgenic limb at climax. The
three remaining glycolytic genes on the array are not regulated
in expression in either the frog limb or the tail at climax.
Whereas the growing limb expresses both cell cycle genes,
mitochondrial energy-related genes, and genes encoding the
glycolytic pathway, the wild type frog limb after metamorphosis
down-regulates the cell cycle genes but continues expressing at a
high level the energy-related genes required for normal func-
tioning skeletal muscle. Many of the same set of energy-related
genes that are up-regulated in the limb by TH and down-
regulated in the tail at climax are repressed in the TRDN
transgenic limb at the climax of metamorphosis (6-week time
point). A complete list of genes on the array that produce
mitochondrial-localized products is presented in Table S4. To
emphasize the similar gene expression response between the
limbs expressing the TRDN transgene and the tail at meta-
morphic climax we have summarized the affected genes that are
expressed in muscle, in mitochondria and in the glycolytic
pathway (Table 4). Listed are the number of primary candidate
genes for the limb phenotype (down-down-up, down-ns-up),
secondary candidate genes (ns-ns-up) and genes that do not
change (ns-ns-ns). Most of the limb muscle candidate genes are
down-regulated in the tail at climax while the genes that do not
change in the transgenic limb also are not changed in the climax
tail.
Other programs in the limb are not affected by the TRDN
transgene
This microarray analysis confirms the cell autonomous
nature of the muscle phenotype (Brown et al., 2005; Das et al.,
2002). The most extreme expression profiles on the arrays
demonstrate this independence. The 40 most up-regulated genesTable 4
Many candidate genes in the limb are regulated in the tail at climax
Tail NF62
ns up down
Mitochondria ( Suppl. Table 4)
ns-ns-ns (183) 156 9 18
ns-ns-up (141) 72 1 68
down-down-up (2) 1 1
down-ns-up (2) 2
Muscle ( Suppl. Table 1)
ns-ns-ns (49) 41 4 4
ns-ns-up (47) 24 2 21
down-down-up (11) 2 9
down-ns-up (13) 2 11
Glycolysis ( Suppl. Table 3)
ns-ns-ns (3) 3
ns-ns-up (11) 11
down-down-up (2) 2
Kinetic categories of gene expression are explained graphically in Fig. 3.
Numbers in parentheses are the number of genes in the limb array in each kinetic
category. The supplementary tables list all of the genes.in the frog limb are also up-regulated at the 6-week time point as
expected for TH-induced genes that are not repressed by the
transgene. These genes include terminally differentiated genes
expressed in adult skin, bone and other non-muscle cell types.
The complete list of expressed genes in these arrays is
accessible through GEO Series accession number GSE5249.
or at our own web site (http://www.ciwemb.edu/brownlab/
index.html).
Discussion
The development of the muscle wasting phenotype
Induction of the TRDN–GFP transgene with Dox began at
NF55 when the pCar promoter first drives a detectable reporter
in developing limb muscle. The transgenic progeny of the
mutant male parent are remarkably uniform in their response.
The 2-week time point was chosen for the microarray because
the tadpoles showed the first morphological external sign of the
limb phenotype, yet they were growing and developing like
controls. A careful analysis of muscle degradation (Fig. 6)
showed beginning fiber damage as early as 2 days after Dox
induction and pervasive muscle fiber destruction after 1 week.
The 50% that are transgenic developed an identical paralyzed
limb phenotype and died shortly after their gills resorbed
(NF62) but before tail resorption. Triplicate samples were
collected at each time point for independent RNA purification
and microarray hybridization so that the results could be
subjected to statistical analysis. A meaningful change in gene
expression required a false discovery rate (FDR) value<0.05. A
control sample for the 6-week time point was not taken. By this
time the muscle fibers are almost completely degenerated in the
transgenic limb (Fig. 2) yet development of the other limb cell
types was unimpaired. We have shown previously (Brown et al.,
2005; Das et al., 2002) that expression of the TRDN transgene
in limb muscle is cell autonomous. The microarray confirms
that many adult specific genes begin to change their expression
at metamorphic climax (the 6-week time point). This not only
includes genes that change in non-muscle cell types such as skin
and bone but a substantial number of muscle genes (Table S1).
In each case the expression level at the 6-week time point is
elevated or suppressed in the same direction as the control frog
limb (ns-up-up or ns-down-down). The complete gene expres-
sion data from these microarray experiments can be obtained
from the NCBI database or our web site (http://www.ciwemb.
edu/brownlab/index.html). Many muscle genes do not change
their expression during development of the limb nor are they
altered in expression by the transgene (ns-ns-ns)(Table S1).
Replicating satellite cells that express Pax7 are abundant even
when muscle degeneration caused by the transgene is extensive
(Fig. S1). The traditional assays for cell death (activated
caspase-3 and TUNEL) are negative in the transgenic limb
muscle cells. Since the expression of the transgene occurs in all
kinds of muscle including cardiac muscle the cause of death in
the transgenic tadpoles is not known. We have considered that
the phenotype might be caused by non-specific toxicity due to
its accumulation in limb muscle nuclei. However expression of
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from the intensity of GFP yet the tail is not only healthy in these
induced transgenic tadpoles, but it is protected from TH-
induced resorption by the transgene (Das et al., 2002).
Furthermore, the limb muscle cells remain alive, and the
expression of most of the muscle genes on the array is not
altered by the transgene (Figs. S1 and S2; Table S1).
Candidate TH-regulated muscle genes
The microarray probably contains no more than half of all of
the X. laevis expressed genes an obvious limitation to a
comprehensive search for a candidate gene(s). Nevertheless this
microarray analysis has revealed a small number of muscle genes
(Table 2) that have the expression profile expected of a primary
candidate to account for muscle degeneration and many more
muscle genes whose activity is influenced secondarily by the
phenotype (Tables S1–S4). A gene that is inhibited from being
down-regulated in limbmuscle at metamorphosis might cause the
necrosis phenotype. In that case the transgene is expected to up-
regulate that gene at the 2-week induction time point (up-up-
down, Fig. 4E). However there are only three genes with this
expression profile on the entire array. Their expression change is
small, and they have no relationship to muscle. The collection of
genes with the opposite profile (down-down-up or down-ns-up) is
much more relevant to the muscle phenotype. These genes are
normally up-regulated in limb muscle at metamorphosis but are
repressed by the transgene. The majority of the 32 primary
candidate genes on the array with this profile (Table 2) are
expressed in muscle. The expression of many more muscle genes
rise significantly in the frog limb muscle but are unchanged at 2
and 6 weeks of transgene exposure (ns-ns-up) (Table S2) an
expression profile that can be secondarily attributed to the
transgene. The suppression of these genes at the 6-week time
point is likely to be the result rather than the cause of muscle
degeneration. We have sought to determine the gene(s) directly
responsible for the degradation phenotype by assaying their
expression at varying times of Dox induction. Most of the
candidate genes have been verified by in situ hybridization with
regard to their muscle expression and down-regulation at the 6
week time point (Table 2). We screened the down-regulation
kinetics of six of the most dramatically affected genes (Table 3).
Five out of six were significantly down-regulated 4 days after the
addition of Dox, but only calsequestrin was down-regulated
before the appearance of muscle degradation at 1 day (Fig. 7).
The role of calcium in muscle degeneration
Calsequestrin is one of several of the candidate genes that are
involved in calcium availability, the reuptake of Ca++ in
skeletal muscle and muscle contraction. Calsequestrin is
reduced in some patients with Duchenne and Becker type
muscular dystrophy (Lucas-Heron et al., 1989), but no
phenotype has been reported for calsequestrin knockouts. The
protein is located in the terminal cisternae of the sarcoplasmic
reticulum and functions as a calcium storage protein. The
sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) plays animportant role in uptake of calcium into muscle fibers
(MacLennan et al., 1997). Mutations in this gene have been
associated with Brody's disease a disorder that reduces the
relaxation time of fast twitch muscle (Odermatt et al., 1996).
Troponin C (Hoffmann et al., 2001) and tropomyosin beta
(Donner et al., 2000) mediate Ca++ dependent muscle
contraction. Creatine kinase influences the sequestration of
Ca++ in muscle (Steeghs et al., 1997). The ryanodine receptors
(RyR) are intracellular calcium release channels that regulate
calcium transport in cardiac and skeletal muscle. RyR3 is the
only isoform of this calcium release channel on the array. A
knockout of the RyR3 isoform impairs muscle contraction in
new born mice (Bertocchini et al., 1997). Myozenin, also called
calsarcan, is a calcineurin binding protein. The down-regula-
tion of one or more of these proteins might cause an
uncontrolled surge of calcium that activates calpains. These
calcium dependent muscle specific proteases can lead to
rhabdomyolysis (Gissel, 2006). The disruption of muscle fibers
in the TRDN phenotype (Fig. 2) resembles this condition more
than it does typical wasting dystrophies.
Other primary candidate genes are implicated in myopathies
Considering the interdependency of proteins that make up
muscle fibers it is not surprising that mutations in a large
number of genes cause muscle wasting. Even single mutations
in a gene that encodes a contractile protein can disrupt the
structure of myofibrils (Karlik et al., 1984). Several of the genes
that are primary candidates to account for the muscle
degeneration are known to be associated with mammalian
myopathies. This phenotype has been documented either as a
result of gene knock outs in the mouse or as known human
mutations. Mutations in enolase (Comi et al., 2001) and
phosphoglucomutase (DiMauro et al., 1981), genes that encode
glycolysis enzymes, cause human “metabolic” myopathies.
Both of these genes have isomers represented on the microarray
that are expressed in other tissues. The non-muscle isomers are
not influenced by the transgene. Most of the remaining genes
that encode glycolytic enzymes behave like secondary response
genes (ns-ns-up) (Table S3). The frog limb has highly elevated
expression of these same glycolytic genes, and every one of
these genes that has either a primary or secondary candidate
profile is depressed in tail muscle at climax. The same few
glycolytic genes that are unchanged in the limb array (ns-ns-ns)
are unchanged in the tail at climax. A profile of gene expression
changes in denervated rat muscle found many genes down-
regulated that encode both glycolysis and electron transport in
mitochondria (Batt et al., 2006).
Deficiency of the alpha 1 form of actin is responsible for
nemaline myopathy (Ilkovski et al., 2001). The expression of
this gene is strongly depressed in the transgenic limbs and the tail
at climax. A gene encoding a muscle-specific isomer of
elongation factor E1alpha 2 is dramatically up-regulated in the
frog limb but suppressed (ns-ns-up) in the transgenic limbs.
Mutations in this gene have been implicated in a human wasting
disorder (Chambers et al., 1998). Three subunits of the nicotinic
cholinergic receptor (alpha, delta, and epsilon) are amongst the
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gene while the fifth subunit (gamma) is down-regulated in the
frog limb. We have followed the development of the acetylcho-
line receptor in growing limbs using fluorescent alpha-
bungarotoxin. The degraded muscle caused by the transgene
has visible receptors that do not cluster at the nerve endings (data
not shown).
Many of the same genes that are repressed by the transgene in
the limb are down-regulated in tail when it resorbs
TH induces the tail muscle of normal tadpoles to die and the
limb muscle to grow. These programs are reversed when the
TRDN is expressed in muscle. The tail muscle of a transgenic
tadpole becomes resistant to TH (Das et al., 2002) while the
limb muscle degenerates (Fig. 6). We observed (Das et al.,
2006) that many of the same individual genes in several
different functional pathways are regulated together but in
opposite directions in the dying tail muscle at metamorphic
climax compared to the TH-induced limb muscle. TH up-
regulates many genes that encode glycolytic enzymes and
energy related proteins in the mitochondria of the growing limb
and down-regulates them in tail muscle at climax. We have
extended this observation in these studies to the genes whose
expression is influenced by the TRDN transgene. The majority
of genes that do not change during development or in transgenic
limbs are unchanged in tail muscle at climax. The candidate
limb muscle genes that are down-regulated by the transgene in
the limb are also down-regulated in the tail at metamorphic
climax (Table 2). Table 4 summarizes the extent that three
functional groups of muscle genes, those involved in mitochon-
drial energy metabolism, cytoplasmic-localized glycolysis, and
muscle contraction and maintenance have a gene expression
response caused by the TRDN transgene in the limb that is
similar to the tail resorption program. Introduction of the TRDN
transgene changes a limb growth program into a muscle
resorption program by down-regulating many of the same group
of genes that are normally expressed actively in functioning
muscle. There are no transcription factors amongst the list of
primary candidates (Table 2) that could explain this wholesale
reversal of gene expression programs. However, one candidate
gene, sirtuin, is involved in chromatin remodeling. Sirtuin has
been reported to interact with nuclear receptor cofactors (Picard
et al., 2004). The TRDN has an intact DNA binding domain and
should bind to the same thyroid receptor response elements in
DNA sequences as the unliganded thyroid receptor. However,
the TRDN has lost an important site for coactivator binding in
its C-terminus so that transcription complexes that surround the
TR-response genes in muscle might be unable to release a
bound corepressor thereby insuring a TH-resistant repression of
a whole group of genes. The limb muscle growth and the tail
muscle death program may have more in common than ever
suspected. The TR may bind to the same set of genes but with
opposite regulatory affects. By exchanging a dominant negative
form of the receptor for the normal TH-responsive receptor a set
of genes in limb muscle have changed their growth program to a
resorption program.Acknowledgments
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